SurGenTec Publishes Clinical Reference Resource on Bone Marrow Biopsy Needles
August 26, 2026 - PRESSADVANTAGE - SurGenTec has published a reference resource on the Jamshidi needle, covering the
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
August 26, 2026 – PRESSADVANTAGE –
SurGenTec has published a reference resource on the Jamshidi needle, covering the instrument’s design, technique considerations and role in bone marrow biopsy and aspiration procedures.
The resource is intended for clinicians performing these procedures, according to the company. Representatives said the material addresses design characteristics, handling and technique factors, and that it functions as a reference rather than a substitute for procedural training or institutional protocol.
Bone marrow sampling supports diagnosis across a range of hematologic conditions, according to the company. Representatives said the resource describes the procedural context in which the instrument is used without addressing diagnostic interpretation, which they said falls outside its scope.
Design and instrument history are covered in one section, according to representatives. They said the material traces how the needle’s configuration developed and what the design is intended to accomplish, including features affecting handling during a procedure.
Technique considerations are addressed separately, according to the company. Representatives said the section covers handling and instrument care, and that it presents general considerations rather than directing clinical decisions, which remain with the practitioner and the institution’s protocols.
Clinicians using a Jamshidi needle work within established procedural standards, according to representatives. They said the resource is written to complement those standards rather than propose alternatives to them, and that specimen quality depends on factors beyond instrument selection alone.
Developments in biopsy technology receive a separate section, according to the company. Representatives said this covers imaging and materials developments relevant to the instrument category, and that it describes directions in the field rather than making claims about products.
The material is provided without cost to healthcare professionals, according to representatives. They said access is through the company’s website, and that the resource was developed in response to questions received from clinicians.
The company said the resource is part of ongoing educational material it makes available. Representatives said additional material is planned covering related procedural topics, and that subjects are selected based on what clinicians ask about.
The resource includes a section on terminology, according to representatives. They said instrument naming varies across manufacturers and institutions, and that the material clarifies how terms are used in the literature and where they overlap.
Specimen handling after collection is addressed as well, according to the company. Representatives said the material covers general handling considerations between collection and processing, and notes that laboratory requirements vary by institution and should be confirmed locally.
Training programs account for a portion of the intended audience, according to representatives. They said residents and fellows encountering these procedures early in training were among the groups the material was written for, and that the reference format was chosen with that use in mind.
The company said the material was reviewed before publication. According to representatives, the content was checked against current published literature, and citations are included so clinicians can consult primary sources directly.
Related instruments are covered briefly for context, according to representatives. They said the material notes where different needle configurations are used and how procedural requirements differ, without recommending one over another.
The company said the resource does not constitute clinical guidance. Representatives said clinical decisions rest with treating practitioners and are governed by institutional protocols and applicable professional standards.
Feedback from clinicians will inform revisions, according to the company. Representatives said the material will be updated as procedural standards and available technology change rather than on a fixed schedule.
Healthcare professionals interested in the resource can access it through the SurGenTec website.
###
For more information about SurGenTec, contact the company here:
SurGenTec
SurGenTec
(561) 990-7882
customerservice@surgentec.com
Media gallery

